期刊文献+

原发性乳腺癌组织中端粒酶活性表达与癌细胞凋亡相关性的研究 被引量:6

Association between the expression of telomerase activity and apoptosis in primary breast cancer patients
暂未订购
导出
摘要 目的 :探讨原发性乳腺癌组织中端粒酶活性表达与细胞凋亡发生基因表达的相关性及其预后意义。 方法 :应用端粒酶 TRA P- PCR电泳、银染及 EL ISA法、凋亡细胞原位检测 (TU NEL法 )和 S- P免疫组化染色等技术 ,分别对端粒酶定性和定量测定其活性 (TA)、计算凋亡指数 (AI)、检测凋亡相关基因 Bcl- 2和 p5 3蛋白表达水平。 结果 :TA定性检测平均阳性率为 89.8%、定量测定吸光值中位数 0 .6 3± 0 .2 9,均明显高于正常乳腺和良性病变组织(P<0 .0 5 ) ,其表达阳性率高者预后较差 ,5年累积生存率 (6 0 .3% )低于阴性者 (77.4% ) ,二者有显著差异 (P<0 .0 5 ) ,但酶表达与患者年龄、临床 TNM分期、肿瘤大小、发生部位、病理学类型、淋巴结转移等无关。 AI中位数4.83± 0 .74,与 TA表达高度相关 (r=0 .7331,P <0 .0 5 ) ,凋亡相关基因 Bcl- 2和 p5 3蛋白表达阳性率分别为6 3.4%和 40 .7% ,其中 Bcl- 2表达水平与 TA、AI高低呈高度正相关 (r=0 .7814,P<0 .0 5 ) ,p5 3与之呈负相关 (r=- 0 .6 2 5 5 ,P<0 .0 5 ) ;经多变量 Cox回归分析显示仅 TA、AI对乳腺癌患者生存期有影响 ,TA阳性率高、AI>4.0 %者的平均生存时间短于 TA阴性、AI<4.0 %者 (P<0 .0 5 )。此外 ,术前接受化疗者的 TA表达水平低于未化疗者 (6 4. Objectives:To investigate the association and the prognostic significance of the expression of telomerase activity (TA) and apoptosis (APO) in tissues of primary breast cancer. Methods:TRAP PCR and ELISA were developed to detect the expression of TA, and make quantitative and qualitative analysis respectively. TUNEL was also used to evaluate apoptosis cells in cancer lesions and count apoptosis index (AI). The expression levels of proteins of oncogene Bcl 2 and p53 were measured by means of S P immunohistochemistry. Results: The mean TA positive expression rate was 89.8%, and its mean optic density was ( A ) 0.63± 0.29 , which were significantly higher than those of normal tissues and benign breast lesions ( P <0 05). The 5 years survival rate of patients with positive TA expression was lower (60.3%) than those of negative expression ( 77.4 %). There were no relations between TA expression and patients ages, TNM staging, lymph nodes metastasis, size, locations and pathological types of cancer. But TA was positively correlated with APO ( r = 0.733 1 , P <0 05) and the protein expression of oncogene Bcl 2 ( r = 0.781 4 , P <0 05) and negatively correlated with that of p53 ( r =-0.625 5, P <0 05). Moreover, in patients receiving preoperative chemotherapy, the levels of TA expression were much lower than those without chemotherapy (64.7% vs 85.1%), and the former had higher AI than the latter (7.19 ±3.75% vs 3.23±2.04%), intraarterial chemotherapy group were superior significantly to adjuvant group ( P <0 05). Multivariate Cox Regression Analysis showed that only TA and AI influenced the survival time of primary breast cancer patients, and patients with higher positive TA expression and AI>4.0% had shorter survival time than those of negative TA expression and AI<4.0% patients. Conclusions:There was a significant correlation between TA and APO and its related oncogene Bcl 2, p53. TA and APO are of great diagnostic values, therapeutic helps and prognostic significance in the formation and the development of primary breast cancer.
出处 《医学研究生学报》 CAS 2001年第2期126-131,共6页 Journal of Medical Postgraduates
关键词 原发性乳腺癌 端粒酶 细胞凋亡 病理 Primary breast cancer Telomerase Apoptosis
  • 相关文献

参考文献16

  • 1Kim NW,Piatyszek MA,Prouse K,et al.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266:2011-2021.
  • 2Kerr JFR,Williamson KE,Wilson RH,et al.Apoptosis:its significance in cancer and cancer theropy[J].Cancer,1994,73:2013-2026.
  • 3虞伟,谈华,武建国,季洪爱.端粒重复序列扩增-银染色法用于端粒酶活性测定的研究[J].医学研究生学报,2000,13(2):96-98. 被引量:12
  • 4黄建华,吕新生,刘少华.端粒酶活性在乳腺癌中的表达及临床病理学相关性研究[J].中国普通外科杂志,1999,8(5):363-365. 被引量:3
  • 5Wright WE,Brasiskyte D,Piatyszek MA,et al.Experimental elongation of telomeres extends the lifespan of immortal cell hybrids[J].EMBO J,1996,15:1734-1741.
  • 6Tsao JL,Zhao Y,Lukas J,et al.Telomerase activity in normal and neoplastic breast[J].Clin Cancer Res,1997,3:627-633.
  • 7Koshida Y,Saegusa M,Okayasu I.Apoptosis,cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas:immunohistochemical and clinicopathological study[J].Br J Cancer,1997,75:367-373.
  • 8Fesus I,Szondy Z,Uray I,et al.Probing the molecular program of apoptosis by cancer chemopreventive agents[J].J Cell Biochem Suppl,1995,22:151-161.
  • 9Dong X,Robert T.Bcl expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in Hela cells[J].Cancer res,1995,55:4922-4930.
  • 10Baretton GB,Diebold J,Christoforis G,et al.Apoptosis and immunohistochemical Bcl-2 expression in colorectal adenomas and carcinomas[J].Cancer,1996,77:255-264.

二级参考文献7

  • 1AlbanellJ,HanW,MelladoBetal.Telomeraseactivityisrepressedduringdifferentitationofmaturation-sentiativebutnotresistanthumantumorcelllines[J].CancerRes,1996,56:1503~1508.
  • 2BestilnyLJ,BrownCB,MiuraYetal.Selectiveinhibitionoftelomeraseduringterminaldifferentiationofimmortalcelllines[J].CancerRes,1996,56:3796~3802.
  • 3KimNW,PiatyszekMA,ProwseKRetal.Specificassociationofhumantelomeraseactivatywithimmortalcellsandcancer[J].Science,1994,226:2011.
  • 4GreiderCW,BlackburnEH.ThetelomereterminaltransferaseofTetrahymenaisaribonucleoproteinenzymewithtwokindsofprimerspecificity[J].Cell,1987,57:887~898.
  • 5KlimstraD,VenkatramanE,MooreMAetal.Hightelomeraseactivityinprimarylungcancers:associationwithincreasedcellproliferationratesandadvancedpatholojicstage[J].JNatlCancerInst,1997,809:1609~1615.
  • 6YashimaK,LitzkyLA,KaiserLetal.Telomeraseexpressioninrespiratoryepitheliumduringthemultistagepathogenesisoflungcarcinomas[J].CancerRes,1997,57:2373~2377.
  • 7UedaM,OuhtitA,BitoTetal.EvidenceforUV-associatedactivationoftelomeraseinhumanskin[J].CancerRes,1997,57:370.

共引文献13

同被引文献46

  • 1王少华,于泽平,李宁,杨小冬,张新华,孙桂勤,黎介寿.原发性乳腺浸润性导管癌组织中生长抑素受体表达及其意义[J].医学研究生学报,2005,18(9):805-807. 被引量:8
  • 2顾军,于泽平.原发性双侧乳腺癌的临床分析[J].医学研究生学报,2007,20(6):631-633. 被引量:12
  • 3Heaney AP,Melmed S.Molecular targets in pituitary tumors[J].Nat Rev Cancer,2004,4(4):285-295.
  • 4Reubi JC.Somatostatin and other peptide receptors tools for tumor diagnosis and treatment[J].Neuroendocrinology,2004,80 (Suppl):51-56.
  • 5Florio T,Hong Y,Kendall D,et al.Somatostatin activation of mitogen-activated protein kinase via so matos tatin recptor1(SSTR1)[J].Mol Endocrinol,1999,13(1):24.
  • 6Pages P,Benali N,Saint-Laurent N,et al.sst2 somatostatin recptor mediates cell cycle arrest and induction of p27(Kip1).Evidence for the role of SHP-1[J].Biol Chem,1999,274(21):15186-15193.
  • 7Lahlou H,Guillermet J,Hortala M,et al.Molecular signaling of somatostatin receptors[J].Ann NY Acad Sci,2004,1014:121-131.
  • 8Mahimainathan L,Ghosh-Choudhury N,Venkatesan BA,et al.EGF stimulatesmesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner.Involvement of c-fos and p27Kipl[J].Am J Physiol Renal Physiol,2005,289(1):72.
  • 9Pilichoeska M,Kinura N,Suzuki A,et al.Clinicopathological value of somatostatine type 2A and estrogen receptor immunoreactivity in human breast cancinoma[J].Endocr Pathol,2001,12(1):55-61.
  • 10Rostomily RC,Elias M,Deng M,et al.Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma:a case study and survey of somatotatin receptor subtype expression[J].Heck,2006,489(21):305.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部